Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
- PMID: 1755866
- DOI: 10.1016/0006-291x(91)91276-i
Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
Abstract
Extracellular proteolysis is believed to be an essential component of the angiogenic process. The effects of VEGF, a recently described angiogenic factor, were assessed on PA activity and PA and PAI-1 mRNA levels in microvascular endothelial cells. u-PA and t-PA activity were increased by VEGF in a dose-dependent manner, with maximal induction at 30 ng/ml. u-PA and t-PA mRNAs were increased 7.5- and 8-fold respectively after 15 hours, and PAI-1 mRNA 4.5-fold after 4 hours exposure to VEGF. At equimolar concentrations (0.5 nM), VEGF was a more potent inducer of t-PA mRNA than bFGF, while bFGF was a more potent inducer of u-PA and PAI-1 mRNAs. In addition, VEGF induced u-PA and PAI-1 mRNAs with kinetics similar to those previously demonstrated for bFGF. These results demonstrate the regulation of PA and PAI-1 production by VEGF in microvascular endothelial cells and are in accord with the hypothesis that extracellular proteolysis, appropriately balanced by protease inhibitors, is required for normal capillary morphogenesis.
Similar articles
-
Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.Thromb Haemost. 2001 Aug;86(2):702-9. Thromb Haemost. 2001. PMID: 11522025
-
Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.J Cell Physiol. 1991 Oct;149(1):50-9. doi: 10.1002/jcp.1041490108. J Cell Physiol. 1991. PMID: 1719003
-
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.J Cell Biol. 1990 Aug;111(2):743-55. doi: 10.1083/jcb.111.2.743. J Cell Biol. 1990. PMID: 1696269 Free PMC article.
-
Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.Ann N Y Acad Sci. 1997 Apr 15;811:191-206. doi: 10.1111/j.1749-6632.1997.tb52002.x. Ann N Y Acad Sci. 1997. PMID: 9186598 Review.
-
The role of vascular endothelial cells in the regulation of fibrinolysis.Z Kardiol. 1989;78 Suppl 6:25-9. Z Kardiol. 1989. PMID: 2694664 Review.
Cited by
-
Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection.Int J Colorectal Dis. 2013 Mar;28(3):415-24. doi: 10.1007/s00384-012-1570-z. Epub 2012 Sep 9. Int J Colorectal Dis. 2013. PMID: 22961433
-
HIF-mediated endothelial response during cancer progression.Int J Hematol. 2012 May;95(5):471-7. doi: 10.1007/s12185-012-1072-3. Epub 2012 May 8. Int J Hematol. 2012. PMID: 22562456 Review.
-
Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity.Biochem J. 2001 Feb 1;353(Pt 3):569-78. doi: 10.1042/0264-6021:3530569. Biochem J. 2001. PMID: 11171054 Free PMC article.
-
Aqueous humor IL-8, IL-10, and VEGF levels in Fuchs' uveitis syndrome and Behçet's uveitis.Int Ophthalmol. 2019 Nov;39(11):2629-2636. doi: 10.1007/s10792-019-01112-w. Epub 2019 May 7. Int Ophthalmol. 2019. PMID: 31065903
-
Fit for the Eye: Aptamers in Ocular Disorders.Nucleic Acid Ther. 2016 Jun;26(3):127-46. doi: 10.1089/nat.2015.0573. Epub 2016 Jan 12. Nucleic Acid Ther. 2016. PMID: 26757406 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous